Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy
Eduardo Garcia-Gras, … , Dirar S. Khoury, Ali J. Marian
Eduardo Garcia-Gras, … , Dirar S. Khoury, Ali J. Marian
Published July 3, 2006
Citation Information: J Clin Invest. 2006;116(7):2012-2021. https://doi.org/10.1172/JCI27751.
View: Text | PDF
Research Article Cardiology

Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy

  • Text
  • PDF
Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is a genetic disease caused by mutations in desmosomal proteins. The phenotypic hallmark of ARVC is fibroadipocytic replacement of cardiac myocytes, which is a unique phenotype with a yet-to-be-defined molecular mechanism. We established atrial myocyte cell lines expressing siRNA against desmoplakin (DP), responsible for human ARVC. We show suppression of DP expression leads to nuclear localization of the desmosomal protein plakoglobin and a 2-fold reduction in canonical Wnt/β-catenin signaling through Tcf/Lef1 transcription factors. The ensuing phenotype is increased expression of adipogenic and fibrogenic genes and accumulation of fat droplets. We further show that cardiac-restricted deletion of Dsp, encoding DP, impairs cardiac morphogenesis and leads to high embryonic lethality in the homozygous state. Heterozygous DP-deficient mice exhibited excess adipocytes and fibrosis in the myocardium, increased myocyte apoptosis, cardiac dysfunction, and ventricular arrhythmias, thus recapitulating the phenotype of human ARVC. We believe our results provide for a novel molecular mechanism for the pathogenesis of ARVC and establish cardiac-restricted DP-deficient mice as a model for human ARVC. These findings could provide for the opportunity to identify new diagnostic markers and therapeutic targets in patients with ARVC.

Authors

Eduardo Garcia-Gras, Raffaella Lombardi, Michael J. Giocondo, James T. Willerson, Michael D. Schneider, Dirar S. Khoury, Ali J. Marian

×

Figure 1

Suppression of DP expression in HL-1 cells and nuclear localization of PG.

Options: View larger image (or click on image) Download as PowerPoint
Suppression of DP expression in HL-1 cells and nuclear localization of P...
(A) Immunoblots showing expression levels of DP, PG, β-catenin, and α-tubulin — the latter as a control for loading conditions — in control cells, cells stably transfected with siRNAs against DP, and cells transfected with siRNA against GFP. (B) Immunoblots of subcellular protein extracts probed with an anti-PG antibody. PG was predominantly localized to cytoplasmic protein extracts in control HL-1 cells or cells transfected with siRNA against GFP. In contrast, PG was localized predominantly in the nuclear subfractions in DP-deficient HL-1 cells. (C) Immunofluorescence detection of PG in the nuclei. Shown are cells stained with an anti-PG antibody (left panels), nuclei stained with DAPI (middle panels), and the overlay (right panels) in nontransfected control cells (top panels), cells transfected with siRNA against GFP (middle panels), and DP-deficient HL-1 cells (bottom panels). Magnification, ×400.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts